| Name of the Instrument/Tool | Rheumatoid Arthritis Symptom Questionnaire (RASQ) |
| First Description |
Banderas B, Skup M, Shields AL, Mazar I, Ganguli A. Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis. Curr Med Res Opin. 2017;33(9):1643-1651. doi:10.1080/03007995.2017.1338562 |
| Year | 2017 |
| Domains | |
| Concept of constructs | Disease activity, Fatigue, Functional status, Pain, Stiffness |
| Population/Disease | Disease specific |
| Originally developed for | Rheumatoid Arthritis (RA) |
| Other rheumatic diseases where can be applied (only if validated) |
--- |
| Additional population with no rheumatic diseases |
No |
| Language: Originally published in | English |
| Available in Language | --- |
| REFERENCE IDENTIFICATION | |
| Author/s | Banderas B, Skup M, Shields AL, Mazar I, Ganguli A. |
| Title | Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis. |
| Journal | Curr Med Res Opin. |
| Year | 2017 |
| Vol | 33 |
| Num | 9 |
| Pages | 1643-1651. |
| Country | USA |
| Language | English |
| Other references of interest | |
| Link | https://pubmed.ncbi.nlm.nih.gov/28885061/ |
| Brief Description |
Psychometric evaluation of the RASQ in an observational study. |
| Link | https://pubmed.ncbi.nlm.nih.gov/24550173/ |
| Brief Description |
This article aimed to estimate the global burden of rheumatoid arthritis. |
| Instrument/Tool Translations References | |
| No other References. | |
| DEVELOPER CONTACT INFORMATION | |
| Correspondence to | Benjamin Banderas |
| benjamin.banderas@adelphivalues.com | |
| Address | Adelphi Values, 290 Congress St., Boston, MA 02210 |
| Website | --- |
| Available | --- |
| Links | --- |
| DESCRIPTION OF THE INSTRUMENT | |
| Type Of Measure | Questionnaire |
| Brief Description |
The RASQ is a questionnaire that aims to assess the most important and relevant signs and symptoms of RA. It measures joint pain, joint swelling, joint stiffness, joint tenderness, joint warmth, muscle pain, fatigue, and includes a global item to assess the impact of RA on patients’ lives. Three versions with different recall periods (24 hours and seven days) as well as different ratings of RA signs and symptoms (on average and at their worst) were created to support the RASQ’s use in various contexts. |
| Number of Items | 8 |
| Range | --- |
| Responses options/scale |
Yes Eleven-point NRS from 0 (“No sign/symptom at all”) to 10 (“Worst possible sign/symptom”). |
| Developed for | Clinical practice, Research |
| PRACTICAL APPLICATION | |
| Method of administration | Self-administered |
| Recommendations to score |
The RASQ Total Symptom Score is calculated by summing and averaging Items 1–7. Item 8 does not contribute to the Total Symptom Score |
| Score Interpretation | Higher scores indicate more RA-related symptoms |
| Cut-off points | --- |
| Cut-off points applied to | --- |
| Smallest detectable change if described | --- |
| Smallest detectable change applied to | --- |
| Completion time by the patient | - minutes |
| Scoring time by the assessor | - minutes |
| Training to score | Not necessary |
| Strengths | Easy to use |
| Limitations | Not widely used |
| OTHER COMMENTS | |
| Other Comments | --- |